(Q39806423)

14 September 2017

1 reference

title

Treatment of hepatitis C infections with interferon: a historical perspective (English)

1 reference

14 September 2017

Robert M Friedman

1

1 reference

PMC publication ID

2989738

14 September 2017

Sara Contente

series ordinal

2

1 reference

14 September 2017

6 September 2010

1 reference

Hepatitis Research and Treatment

14 September 2017

1 reference

14 September 2017

2010

1 reference

14 September 2017

323926

1 reference

Creative Commons Attribution 3.0 Unported

14 September 2017

start time

6 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Telaprevir for previously treated chronic HCV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Hepatitis C virus: molecular biology & current therapeutic options.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Predicting response to hepatitis C therapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Peginterferon and ribavirin for chronic hepatitis C.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Lambda interferon inhibits hepatitis B and C virus replication

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Management of cutaneous melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Expression of the human fibroblast interferon gene in Escherichia coli

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Human Leukocyte Interferon in the Treatment of Varicella in Children with Cancer: a Preliminary Controlled Trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Letter: Interferon treatment of dendritic keratitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Inhibition of respiratory virus infection by locally applied interferon

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Risk for renal cell carcinoma in chronic hepatitis C infection

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

RIGorous detection: exposing virus through RNA sensing.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

A step forward in therapy for hepatitis C.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Necessities of interferon therapy in elderly patients with chronic hepatitis C.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Racial differences in response to interferon-based antiviral therapy for hepatitis C virus infection: a hardwiring issue?

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Chronic hepatitis B--new goals, new treatment.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Hepatitis B Virus Infection

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2989738

Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F323926

Interferon produced by Cultures of Calf Kidney Cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F323926

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

21 January 2018

1 reference

12 December 2020

Are anti-interferon antibodies the cause of failure in: chronic HCV hepatitis treatment?

1 reference

12 December 2020

Interferon-Albumin Conjugate with Conserved Biological Activity

1 reference

12 December 2020

EXPERIMENTS WITH INTERFERON IN MAN: A REPORT TO THE MEDICAL RESEARCH COUNCIL FROM THE SCIENTIFIC COMMITTEE ON INTERFERON

1 reference

12 December 2020

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

1 reference

12 December 2020

Partial purification of human leukocyte interferon on a large scale

1 reference

12 December 2020

Identifiers

DOI

10.1155/2010/323926

1 reference

14 September 2017

1 reference

PMC publication ID

2989738

14 September 2017

PubMed publication ID

21152181

1 reference

PMC publication ID

2989738